Abstract
Selective muscarinic antagonists were used in an attempt to characterize the muscarinic autoreceptor modulating the release of acetylcholine in the striatum of the rat. In vivo microdialysis was applied to infuse atropine, 4-DAMP (4-diphenylacetoxy-N-methylpiperidine), pirenzepine or AF-DX 116 (11-[[2-[(diethylamino)methyl]-1- piperidinyl]acetyl]-5, 11-dihydro[2,3-b][1,4]benzodiazepine-6-one), leading to a dose-dependent increase in the overflow of acetylcholine, the order of potency being: atropine > 4-DAMP > pirenzepine > AF-DX 116. We conclude from these data that the muscarinic receptor modulating release in the striatum is of the M 3 type.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have